Neuralink Progresses Human Trials for Brain-Computer Interface Implants

Neuralink is advancing human clinical trials for its brain-computer interface (BCI) implant technology, focusing on individuals with paralysis, including those with conditions like ALS. The trials aim to evaluate the device's efficacy and safety, with a computer science student contributing to the development of testing systems.